InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Septerna, Inc.

SEPN Clue Score47
United States Fiscal year ends December CIK 0001984086 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

53
Insider
Date
Role
Action
Shares
Price
Amount
Elizabeth Bhatt
15 Oct 2026
President and COO
Sold after exercise
2,906
$37.61
$109.31K
Elizabeth Bhatt
15 Oct 2026
President and COO
Sold after exercise
1,094
$36.87
$40.34K
Daniel D. Long
1 Sep 2026
SVP, Drug Discovery
Sold after exercise
3,333
$37.83
$126.08K
Ra Capital Management, L.p.
12 Aug 2026
Director
Sell indirect
746,500
$42.50
$31.73M
Ra Capital Management, L.p.
12 Aug 2026
Director
Sell indirect
746,500
$42.50
$31.73M
Third Rock Ventures V, L.P.
12 Aug 2026
10% owner
Sold on a plan
141
$51.08
$7.20K
Third Rock Ventures V, L.P.
12 Aug 2026
10% owner
Sold on a plan
147,059
$50.27
$7.39M
Elizabeth Bhatt
11 Aug 2026
President and COO
Sold after exercise
25,000
$44.00
$1.10M
Daniel D. Long
3 Aug 2026
SVP, Drug Discovery
Sold after exercise
2,334
$34.68
$80.94K
Daniel D. Long
3 Aug 2026
SVP, Drug Discovery
Sold after exercise
1,000
$33.98
$33.98K
Elizabeth Bhatt
15 Jul 2026
President and COO
Sold after exercise
4,000
$33.99
$135.97K
Daniel D. Long
1 Jul 2026
SVP, Drug Discovery
Sold after exercise
1,233
$34.81
$42.93K
Daniel D. Long
1 Jul 2026
SVP, Drug Discovery
Sold after exercise
2,100
$34.10
$71.60K
Samira Shaikhly
29 Jun 2026
Chief People Officer
Sold after exercise
2,178
$35.18
$76.62K
Daniel D. Long
22 Jun 2026
SVP, Drug Discovery
Sold after exercise
7,000
$35.97
$251.78K
Daniel D. Long
22 Jun 2026
SVP, Drug Discovery
Sold after exercise
8,000
$35.10
$280.80K
Samira Shaikhly
12 Jun 2026
Chief People Officer
Sold after exercise
6,250
$35.08
$219.22K
Samira Shaikhly
1 Jun 2026
Chief People Officer
Sold after exercise
2,889
$29.66
$85.70K
Samira Shaikhly
1 Jun 2026
Chief People Officer
Sold after exercise
1,346
$28.79
$38.76K
Samira Shaikhly
1 Jun 2026
Chief People Officer
Sold after exercise
1,700
$27.78
$47.23K
Samira Shaikhly
26 May 2026
Chief People Officer
Sold after exercise
11,798
$30.06
$354.66K
Elizabeth Bhatt
15 Apr 2026
President and COO
Sold after exercise
326
$25.86
$8.43K
Elizabeth Bhatt
15 Apr 2026
President and COO
Sold after exercise
1,101
$25.24
$27.79K
Elizabeth Bhatt
15 Apr 2026
President and COO
Sold after exercise
2,573
$23.76
$61.12K
Samira Shaikhly
2 Mar 2026
Chief People Officer
Sold after exercise
66,363
$28.14
$1.87M
Samira Shaikhly
2 Mar 2026
Chief People Officer
Sold after exercise
4,090
$27.51
$112.50K
Elizabeth Bhatt
18 Feb 2026
President and COO
Sold after exercise
1,800
$29.58
$53.25K
Elizabeth Bhatt
18 Feb 2026
President and COO
Sold after exercise
2,200
$28.46
$62.61K
Daniel D. Long
10 Nov 2025
SVP, Drug Discovery
Sell
3,501
$18.06
$63.22K
Uwe Klein
18 Aug 2025
SVP, Biological Sciences
Exercised, kept
7,621
$6.81
$51.90K
Uwe Klein
18 Aug 2025
SVP, Biological Sciences
Exercised, kept
4,935
$2.76
$13.62K
Uwe Klein
18 Aug 2025
SVP, Biological Sciences
Exercised, kept
10,452
$2.76
$28.85K
Jeffrey Finer
3 Apr 2025
CEO and President
Exercised, kept
5,000
$2.76
$13.80K
Jeffrey Finer
2 Apr 2025
CEO and President
Exercised, kept
50,000
$2.76
$138.00K
Alan Ezekowitz
7 Mar 2025
Director
Buy
13,319
$6.93
$92.27K
Alan Ezekowitz
6 Mar 2025
Director
Buy
41,355
$6.00
$248.13K
Alan Ezekowitz
5 Mar 2025
Director
Buy
37,835
$5.82
$220.26K
Alan Ezekowitz
4 Mar 2025
Director
Buy
7,491
$6.35
$47.54K
Gil M Labrucherie
27 Feb 2025
Chief Financial Officer
Buy indirect
3,718
$5.85
$21.75K
Jeffrey Finer
27 Feb 2025
CEO and President
Buy
3,000
$5.80
$17.40K
Jeffrey Finer
26 Feb 2025
CEO and President
Buy
4,000
$5.70
$22.80K
Gil M Labrucherie
25 Feb 2025
Chief Financial Officer
Buy indirect
6,282
$5.59
$35.12K
Jeffrey Finer
25 Feb 2025
CEO and President
Buy
10,000
$5.68
$56.77K
Third Rock Ventures VI, L.P.
24 Feb 2025
10% owner
Buy
18,861
$6.00
$113.15K
Gil M Labrucherie
21 Feb 2025
Chief Financial Officer
Buy indirect
5,000
$5.85
$29.25K
Third Rock Ventures VI, L.P.
21 Feb 2025
10% owner
Buy
427,668
$5.94
$2.54M
Gil M Labrucherie
20 Feb 2025
Chief Financial Officer
Buy indirect
14,500
$5.88
$85.23K
Third Rock Ventures VI, L.P.
20 Feb 2025
10% owner
Buy
612,674
$5.92
$3.63M
Gil M Labrucherie
19 Feb 2025
Chief Financial Officer
Buy indirect
10,500
$5.51
$57.81K
Third Rock Ventures V, L.P.
28 Oct 2024
10% owner
Buy indirect
279,500
$18.00
$5.03M
Third Rock Ventures V, L.P.
28 Oct 2024
10% owner
Buy
370,500
$18.00
$6.67M
Ra Capital Management, L.p.
28 Oct 2024
Director
Buy indirect
341,600
$18.00
$6.15M
Ra Capital Management, L.p.
28 Oct 2024
Director
Buy indirect
3,828,400
$18.00
$68.91M

What was left out

Form 4 filings counted 61
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 24
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 10,730,209
History held since 28 Oct 2024